that was a nice jump on good volume on a very bad day - one of my few greens
no debt, and we're trading at cash, with a promising phase 3 drug, and good management - I don't get it - market cap isn't but a little turd in the bucket for big pharma - why aren't we getting scooped up ?
from what I've read, it has superior results, but is difficult to stay on due to adverse effects - thoughts ?
I was just about to post something along similar lines - even if aldo results are shown to be the same as dox, it's still better because of the safety profile
there are four big boys that want this company - pcyc went for +/- 21 billion - market cap of mdvn is +/- 10 billion - I think this has a long way to run to the upside
Sentiment: Strong Buy